News Conference News EuroPCR 2025 Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage Yael L. Maxwell May 21, 2025
News Conference News SCAI 2025 Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR L.A. McKeown May 02, 2025
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Conference News EuroPCR 2020 ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead Yael L. Maxwell July 03, 2020
News Conference News ESC 2019 Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease L.A. McKeown September 05, 2019
News Conference News ACC 2019 COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI L.A. McKeown March 18, 2019
News Conference News ISET 2017 Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360 Caitlin E. Cox February 07, 2017
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News TCT 2015 Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS October 15, 2015